Article

Stigma and Lung Cancer

Author(s):

An article recently published in a special issue of CURE focused on lung cancer, “Quitting Smoking Is Possible and Reduces Cancer Risk,” has generated discussion on social media and in our Discussion Forum.

An article recently published in a special issue of CURE focused on lung cancer, “Quitting Smoking Is Possible and Reduces Cancer Risk,” has generated discussion on social media and in our Discussion Forum.

While the article explains and lists several non-smoking-related causes of lung cancer, it also discusses some of the health risks associated with smoking and suggests ways to modify these risks through proven, effective smoking-cessation programs.

There is no doubt that smoking greatly increases the risk of lung and other cancers, and that smoking cessation through various means has lowered the number of lung cancer cases and mortality. An article covering these topics is in line with CURE’s commitment to addressing modifiable cancer risks.

We believe that there should be NO STIGMA associated with lung cancer, regardless of whether a patient or survivor is a smoker, a former smoker or a never-smoker.

We support research and funding for all diseases that affect us, regardless of causality, as well as the education of the cancer community about these important issues.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content